A new role for miR-939 in breast cancer is proposed.
miR-939 interaction with lymph node status predicts worse prognosis in TNBCs.
miR-939 is released in exosomes and regulates VE-cadherin in endothelial cells.
Down modulation of VE-cadherin enhances cancer cells trans-endothelial migration.